Shi, V., Bhutani, T., Deleuran, M., Fonacier, L., Shumack, S., Zhang, F., Cameron, M.C. , Chan, G.L., Valdez, H. and Yin, N. 2023. Abrocitinib in the Treatment of Moderate-to-Severe Atopic Dermatitis Refractory to Dupilumab Treatment: An Analysis of JADE-EXTEND, a Phase 3 Long-Term Extension Study. SKIN The Journal of Cutaneous Medicine. 7, 2 (Mar. 2023), s153. DOI:https://doi.org/10.25251/skin.7.supp.153.